Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01UBY
|
|||
| Former ID |
DNCL002875
|
|||
| Drug Name |
JNJ-41443532
|
|||
| Synonyms |
UNII-0OJB0LES1A; JNJ-41443532; 0OJB0LES1A; CHEMBL2204263; CFKBNYUHQSQBSX-UHFFFAOYSA-N; 1228650-83-6; SCHEMBL2485329; SCHEMBL2485331; SCHEMBL2545786; SCHEMBL13302364; BDBM50400695; DB12632; Benzamide, N-(2-((1-(trans-4-hydroxy-4-(5-thiazolyl)cyclohexyl)-3-azetidinyl)amino)-2-oxoethyl)-3-(trifluoromethyl)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 2 | [1] | |
| Company |
Janssen Research & Development
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H25F3N4O3S
|
|||
| Canonical SMILES |
C1CC(CCC1N2CC(C2)NC(=O)CNC(=O)C3=CC(=CC=C3)C(F)(F)F)(C4=CN=CS4)O
|
|||
| InChI |
1S/C22H25F3N4O3S/c23-22(24,25)15-3-1-2-14(8-15)20(31)27-10-19(30)28-16-11-29(12-16)17-4-6-21(32,7-5-17)18-9-26-13-33-18/h1-3,8-9,13,16-17,32H,4-7,10-12H2,(H,27,31)(H,28,30)
|
|||
| InChIKey |
CFKBNYUHQSQBSX-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1228650-83-6
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01230749) A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.